Martin W. Britten

Point-of-Care Measurement of Activated Clotting Time for Cardiac Surgery as measured by the Hemochron Signature Eliteand the Abbott i-STAT: Agreement, Concordance, and Clinical Reliability CURRENT STATUS: ACCEPTED

E. Nagy, U. Essen, J. Peters, 2020 .

Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability

J. Peters, D. Dirkmann, Elisabeth Nagy, 2019, BMC Anesthesiology.

Anticoagulant Effect of Sugammadex: Just an In Vitro Artifact

J. Peters, Klaus Görlinger, D. Dirkmann, 2016, Anesthesiology.

Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status

K. Schmid, K. Worm, D. Fuhrer, 2015, BMC Cancer.

Glycocalyx components affect platelet function, whole blood coagulation, and fibrinolysis: an in vitro study suggesting a link to trauma-induced coagulopathy

J. Peters, D. Dirkmann, K. Tominaga, 2021, BMC Anesthesiology.

Point-of-Care-Diagnostik in der Traumatologie – Methoden und Evidenz

D. Dirkmann, M. Britten, U. Frey, 2018, AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie.